Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women

Maturitas

Volumn 41, Issue 2, 2002, Pages 133-141

  Wiegratz, Inka ^a   Starflinger, Franz ^b   Tetzloff, Wolfgang ^c   Leifels Fischer, Beate ^b   Helmond, Frans A ^d   Dericks Tan, Jeanne S E ^a   Kuhl, Herbert ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MDS Pharma Services ^*

^c MDS Pharma Services   (Germany)

^d NV ORGANON   (Netherlands)

Author keywords

Carbohydrate; Glucose; Insulin; Tibolone

Indexed keywords

C PEPTIDE; ESTROGEN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MEDROGESTONE; TIBOLONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EQUIDAE;

EID: 0037176780     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00278-X     Document Type: Article

References (21)

1. Livial: A review of clinical studies
2. Prevention of post-menopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17β-estradiol and dydrogesterone
3. A randomized study of tibolone on bone mineral density in osteoporotic post-menopausal women with previous fractures
4. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in post-menopausal osteoporotic women with and without previous fractures
5. Long-term placebo-controlled efficacy and safety study of Org OD14 in climacteric women
6. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints
7. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in post-menopausal women with menopausal symptoms
8. Human endometrial 3β-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14)
9. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD 14) and its metabolites on human endometrium
10. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
11. Hyperinsulinemia as an independent risk factor for ischemic heart disease
12. A double-blind cross-over study on the effects of ORG OD 14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women
13. Effect of tibolone on glucose and lipid metabolism in post-menopausal women
14. Insulin resistance, secretion, and metabolism in users of oral contraceptives
15. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in post-menopausal women
16. A possible bimodal effect of estrogen on insulin sensitivity in post-menopausal women and the attenuating effect of added progestin
17. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile
18. Menstrual cyclicity has a profound effect on glucose homeostasis
19. Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus
20. Short-term blood pressure and metabolic effects of tibolone in post-menopausal women with non-insulin dependent diabetes
21. Short-term metabolic effects of tibolone in post-menopausal women with non-insulin dependent diabetes mellitus